申请人:Gilead Sciences, Inc.
公开号:US08088771B2
公开(公告)日:2012-01-03
The present invention provides a compound of general Formula (I) having histone deacetylase (HDAC) inhibitory activity, a pharmaceutical composition comprising the compound, and a method useful to treat diseases using the compound.
本发明提供了一种具有组蛋白去乙酰化酶(HDAC)抑制活性的通式(I)化合物,一种包含该化合物的药物组合物,以及使用该化合物治疗疾病的有用方法。